ReviewJournal for immunotherapy of cancer2021

Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR.

Nicholas L Bayless et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.